DE602005017879D1 - Nichtpeptidinhibitoren von matrixmetalloproteinasen - Google Patents
Nichtpeptidinhibitoren von matrixmetalloproteinasenInfo
- Publication number
- DE602005017879D1 DE602005017879D1 DE602005017879T DE602005017879T DE602005017879D1 DE 602005017879 D1 DE602005017879 D1 DE 602005017879D1 DE 602005017879 T DE602005017879 T DE 602005017879T DE 602005017879 T DE602005017879 T DE 602005017879T DE 602005017879 D1 DE602005017879 D1 DE 602005017879D1
- Authority
- DE
- Germany
- Prior art keywords
- peptidinhibitors
- matrix metal
- compounds
- disclosed
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000035195 Peptidases Human genes 0.000 title 1
- 108091005804 Peptidases Proteins 0.000 title 1
- 239000011159 matrix material Substances 0.000 title 1
- 239000002184 metal Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 abstract 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 abstract 1
- 206010061309 Neoplasm progression Diseases 0.000 abstract 1
- 229940124639 Selective inhibitor Drugs 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000004366 heterocycloalkenyl group Chemical group 0.000 abstract 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000005751 tumor progression Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/20—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
- C07C311/43—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55538004P | 2004-03-22 | 2004-03-22 | |
| PCT/US2005/009263 WO2005092844A1 (en) | 2004-03-22 | 2005-03-21 | Nonpeptide inhibitors of matrix metalloproteinases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602005017879D1 true DE602005017879D1 (de) | 2010-01-07 |
Family
ID=34963517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602005017879T Expired - Lifetime DE602005017879D1 (de) | 2004-03-22 | 2005-03-21 | Nichtpeptidinhibitoren von matrixmetalloproteinasen |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8129406B2 (enExample) |
| EP (1) | EP1735274B1 (enExample) |
| JP (2) | JP2007530546A (enExample) |
| KR (1) | KR20070046025A (enExample) |
| CN (1) | CN101001834B (enExample) |
| AT (1) | ATE449760T1 (enExample) |
| AU (1) | AU2005227311B2 (enExample) |
| CA (1) | CA2560739A1 (enExample) |
| DE (1) | DE602005017879D1 (enExample) |
| DK (1) | DK1735274T3 (enExample) |
| ES (1) | ES2338243T3 (enExample) |
| MX (1) | MXPA06010974A (enExample) |
| NZ (1) | NZ550621A (enExample) |
| PL (1) | PL1735274T3 (enExample) |
| PT (1) | PT1735274E (enExample) |
| SI (1) | SI1735274T1 (enExample) |
| WO (1) | WO2005092844A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008338631A1 (en) | 2007-12-14 | 2009-06-25 | Georgetown University | Histone deacetylase inhibitors |
| GB0817207D0 (en) * | 2008-09-19 | 2008-10-29 | Pimco 2664 Ltd | therapeutic apsac compounds and their use |
| WO2010047803A2 (en) * | 2008-10-22 | 2010-04-29 | Oncotx, L.L.C. | A method for the treatment of proliferative disorders of the eye |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5753653A (en) | 1995-12-08 | 1998-05-19 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| DE69624081T2 (de) | 1995-12-20 | 2003-06-12 | Agouron Pharmaceuticals, Inc. | Matrix-metalloprotease Inhibitoren |
| SK282863B6 (sk) * | 1996-05-17 | 2002-12-03 | Warner-Lambert Company | Bifenylsulfonamidy, ich použitie a farmaceutické prostriedky na ich báze |
| EP0818442A3 (en) | 1996-07-12 | 1998-12-30 | Pfizer Inc. | Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor |
| US5977408A (en) | 1996-10-16 | 1999-11-02 | American Cyanamid Company | Preparation and use of β-sulfonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| KR20000049198A (ko) | 1996-10-16 | 2000-07-25 | 윌리암 에이취 캘넌, 에곤 이 버그 | 매트릭스 메탈로프로티나아제 및 ｔａｃｅ 억제제로서의 베타-설폰아미도 하이드록스암산 |
| CN1254337A (zh) * | 1997-03-04 | 2000-05-24 | 孟山都公司 | N－羟基4－磺酰基丁酰胺化合物 |
| GB9708133D0 (en) | 1997-04-22 | 1997-06-11 | British Biotech Pharm | Novel use of matrix metalloproteinase inhibitors |
| US6326516B1 (en) * | 1999-01-27 | 2001-12-04 | American Cyanamid Company | Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors |
| AR035478A1 (es) * | 1999-01-27 | 2004-06-02 | Wyeth Corp | Acido amida-hidroxamico, acido acetilenico, beta-sulfonamido y fosfinico como inhibidores de la tace, uso de los mismos para la manufactura de un medicamento y composicion farmaceutica que los contiene |
| AUPP982399A0 (en) | 1999-04-19 | 1999-05-13 | Fujisawa Pharmaceutical Co., Ltd. | Mmp inhibitor |
| EP1355648A2 (en) * | 2001-01-11 | 2003-10-29 | Bristol-Myers Squibb Pharma Company | 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) |
-
2005
- 2005-03-21 US US10/593,748 patent/US8129406B2/en not_active Expired - Fee Related
- 2005-03-21 AU AU2005227311A patent/AU2005227311B2/en not_active Expired - Fee Related
- 2005-03-21 CA CA002560739A patent/CA2560739A1/en not_active Abandoned
- 2005-03-21 KR KR1020067021920A patent/KR20070046025A/ko not_active Ceased
- 2005-03-21 NZ NZ550621A patent/NZ550621A/en unknown
- 2005-03-21 PL PL05729212T patent/PL1735274T3/pl unknown
- 2005-03-21 ES ES05729212T patent/ES2338243T3/es not_active Expired - Lifetime
- 2005-03-21 DE DE602005017879T patent/DE602005017879D1/de not_active Expired - Lifetime
- 2005-03-21 MX MXPA06010974A patent/MXPA06010974A/es active IP Right Grant
- 2005-03-21 JP JP2007505043A patent/JP2007530546A/ja active Pending
- 2005-03-21 WO PCT/US2005/009263 patent/WO2005092844A1/en not_active Ceased
- 2005-03-21 SI SI200530912T patent/SI1735274T1/sl unknown
- 2005-03-21 CN CN200580016346XA patent/CN101001834B/zh not_active Expired - Fee Related
- 2005-03-21 EP EP05729212A patent/EP1735274B1/en not_active Expired - Lifetime
- 2005-03-21 PT PT05729212T patent/PT1735274E/pt unknown
- 2005-03-21 DK DK05729212.0T patent/DK1735274T3/da active
- 2005-03-21 AT AT05729212T patent/ATE449760T1/de active
-
2011
- 2011-01-21 JP JP2011011407A patent/JP2011079866A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN101001834B (zh) | 2011-06-29 |
| PL1735274T3 (pl) | 2010-05-31 |
| US20080312329A1 (en) | 2008-12-18 |
| WO2005092844A1 (en) | 2005-10-06 |
| JP2011079866A (ja) | 2011-04-21 |
| KR20070046025A (ko) | 2007-05-02 |
| DK1735274T3 (da) | 2010-03-29 |
| EP1735274A1 (en) | 2006-12-27 |
| PT1735274E (pt) | 2009-12-11 |
| NZ550621A (en) | 2009-11-27 |
| ATE449760T1 (de) | 2009-12-15 |
| SI1735274T1 (sl) | 2010-03-31 |
| MXPA06010974A (es) | 2007-04-23 |
| AU2005227311B2 (en) | 2012-03-15 |
| ES2338243T3 (es) | 2010-05-05 |
| US8129406B2 (en) | 2012-03-06 |
| CA2560739A1 (en) | 2005-10-06 |
| JP2007530546A (ja) | 2007-11-01 |
| CN101001834A (zh) | 2007-07-18 |
| EP1735274B1 (en) | 2009-11-25 |
| AU2005227311A1 (en) | 2005-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007016392A3 (en) | Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors | |
| TW200602322A (en) | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs | |
| NO20030896L (no) | Nye dipeptidyl-peptidase IV-inhibitorer og deres anvendelse som anti-kreftmidler | |
| MXPA04001016A (es) | Derivados de sulfonamida como inhibidores de la gamma secretasa. | |
| EA200870117A1 (ru) | Азаиндоловые ингибиторы аурора-киназ | |
| ATE437872T1 (de) | Proteinkinaseinhibitoren | |
| EA200601007A1 (ru) | 7-фенилалкилзамещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза)полимеразы | |
| EA200300428A1 (ru) | Антагонисты метаботропных рецепторов глутамата | |
| EA200600351A1 (ru) | Новые соединения, обладающие ингибирующей активностью в отношении натрийзависимого транспортёра | |
| ATE411078T1 (de) | Acylsulfonamid-verbindungen als inhibitoren der rna-abhängigen rna-polymerase | |
| EA200300763A1 (ru) | Пиридиновые ингибиторы матриксных металлопротеиназ | |
| EA200401062A1 (ru) | Ингибиторы dpiv на основе глутаминила | |
| UA96565C2 (ru) | Пиридильные ингибиторы хеджхоговской передачи сигнала | |
| EA200600509A1 (ru) | Соединения пиримидотиофена | |
| TW200635585A (en) | Monocyclic substituted methanones | |
| EA200601830A1 (ru) | Ортозамещённые арильные или гетероарильные амидные соединения | |
| WO2005092858A3 (en) | Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist | |
| DE60330407D1 (de) | Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung | |
| EA200500342A1 (ru) | Гетероциклические замещённые пиперазины для лечения шизофрении | |
| EA200970171A1 (ru) | Производные n-(аминогетероарил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии | |
| SE0400284D0 (sv) | Novel compounds | |
| DE602004029355D1 (de) | Sulfopyrrolderivate | |
| DE602005025332D1 (de) | 4-ä2-(cycloalkylamino)pyrimidin-4-ylü-(phenyl)imidazolin-2-onderivate als inhibitoren der p38-map-kinase zur behandlung von entzündlichen krankheiten | |
| ATE428693T1 (de) | Prostaglandinsynthese | |
| DE602005017879D1 (de) | Nichtpeptidinhibitoren von matrixmetalloproteinasen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |